Select Asset Management & Trust’s Pfizer PFE Stock Holding History

Select Asset Management & Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$653K	Sell	27,116 -9,091	-25%	-$238K	0.19%	36
2026 Q1	$1.02M	Sell	36,207 -135	-0.4%	-$3.59K	0.32%	26
2025 Q4	$905K	Hold	36,342	–	–	0.28%	28
2025 Q3	$926K	Hold	36,342	–	–	0.29%	32
2025 Q2	$881K	Hold	36,342	–	–	0.3%	32
2025 Q1	$921K	Sell	36,342 -15,880	-30%	-$416K	0.37%	28
2024 Q4	$1.39M	Buy	52,222 +4,110	+9%	+$111K	0.54%	23
2024 Q3	$1.39M	Buy	48,112 +15,178	+46%	+$443K	0.51%	22
2024 Q2	$921K	Sell	32,934 -5,475	-14%	-$151K	0.37%	26
2024 Q1	$1.07M	Buy	38,409 +160	+0.4%	+$4.44K	0.44%	25
2023 Q4	$1.1M	Sell	38,249 -107	-0.3%	-$3.23K	0.54%	23
2023 Q3	$1.27M	Buy	38,356 +307	+0.8%	+$10.9K	0.74%	20
2023 Q2	$1.4M	Sell	38,049 -4,598	-11%	-$179K	0.85%	20
2023 Q1	$1.74M	Buy	42,647 +4,923	+13%	+$213K	1.53%	17
2022 Q4	$1.93M	Hold	37,724	–	–	2.32%	14
2022 Q3	$1.65M	Hold	37,724	–	–	1.97%	15
2022 Q2	$1.98M	Sell	37,724 -12,602	-25%	-$642K	2.13%	17
2022 Q1	$2.6M	Sell	50,326 -79,886	-61%	-$4.14M	2.23%	15
2021 Q4	$7.69M	Buy	130,212 +11,600	+10%	+$575K	5.09%	7
2021 Q3	$5.1M	Sell	118,612 -22,500	-16%	-$997K	3.68%	9
2021 Q2	$5.53M	Buy	141,112 +26,301	+23%	+$1.02M	3.14%	10
2021 Q1	$4.16M	Buy	+114,811	New	+$4.08M	2.77%	13
2015 Q3	–	Sell	-14,246	Closed	-$453K	–	39
2015 Q2	$453K	Hold	14,246	–	–	0.39%	28
2015 Q1	$470K	Hold	14,246	–	–	0.36%	28
2014 Q4	$421K	Hold	14,246	–	–	0.3%	24
2014 Q3	$400K	Sell	14,246 -38,629	-73%	-$1.08M	0.27%	33
2014 Q2	$1.49M	Hold	52,875	–	–	1.4%	24
2014 Q1	$1.61M	Sell	52,875 -21,080	-29%	-$629K	1.51%	22
2013 Q4	$2.15M	Buy	+73,955	New	+$2.15M	1.93%	16

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Select Asset Management & Trust's PFE Position: Q2 2026 in Review

Select Asset Management & Trust reduced its Pfizer (PFE) stake by 25% in Q2 2026, selling an estimated $238K and leaving 27,116 shares worth $653K. The position accounts for 0.19% of the portfolio, ranked #36.

Select Asset Management & Trust first reported a position in PFE in Q4 2013 and has held it in 29 quarters since. The position peaked at $7.69M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Select Asset Management & Trust held 27,116 shares of Pfizer worth $653K as of Q2 2026.
Select Asset Management & Trust sold 9,091 Pfizer shares in Q2 2026, an estimated $238K.
Pfizer made up 0.19% of Select Asset Management & Trust's portfolio in Q2 2026, its #36 holding.
Select Asset Management & Trust first reported a position in Pfizer in Q4 2013 and has held it in 29 quarters since.
Select Asset Management & Trust's Pfizer position peaked at $7.69M in Q4 2021.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Select Asset Management & Trust's 13F filing for Q2 2026, filed 11 Aug 2026.